Navigation Links
Baxter Presents Phase I Inhaled Insulin Study Results at,Respiratory Drug Delivery Conference

Findings Suggest Insulin Powder Produced Using Baxter's PROMAXX Microsphere Technology was Absorbed Systemically with No Reported Cough or Shortness of Breath

PARIS, April 20, 2007 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation announced results of a Phase I study that evaluated pulmonary insulin produced with Baxter's PROMAXX microsphere technology and administered using a small, standard dry powder inhaler. Baxter presented the Phase I data earlier this week at the Respiratory Drug Delivery Europe 2007 Conference in Paris.

The study demonstrates that the insulin powder can be effectively administered to the deep lung using an off-the-shelf dry powder inhaler designed for upper airway drug delivery. A total of 30 subjects participated in the randomized, two-way crossover study conducted in Germany. Each subject received in randomized fashion a single dose of 10 International Units of insulin through subcutaneous injection (SC) in one period, and 6.5 milligrams of the inhaled insulin microspheres, called recombinant human insulin inhalation powder (RHIIP) in the other period.

RHIIP is made using Baxter's proprietary PROMAXX formulation technology. Unlike other dry powder formulations of insulin, RHIIP is 95 percent insulin and does not rely on the use of inactive ingredients to facilitate delivery to the deep lung. In this study, no serious adverse events were reported and no subjects withdrew from the study due to an adverse event. All adverse events were mild in severity. The most common reported treatment-emergent adverse event was phlebitis. There were no reported episodes of cough or shortness of breath in this study.

Study data show that RHIIP had a faster onset of action than SC (time to reach 10 percent of total area under the glucose infusion rate (GIR) curve 73 vs 95 min.; GIR-tmax 173 versus 218 min., p<0.0001). Duration of action (371 vs 366 min.) and total metabolic ef
'"/>




Page: 1 2 3

Related medicine technology :

1. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
(Date:6/30/2015)... 30, 2015   Millar, Inc. , a leader ... the 2016 retirement of Craig Thummel , President/CEO ... years of service to the Company. The Company also ... members of the Executive Management team as his successors. ... , currently Director of Sales and Marketing, as President, ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... Calif. , June 30, 2015  Ardelyx, Inc. ... on cardio-renal, gastrointestinal and metabolic diseases, today announced that ... July 14, 2015, from 8:00 a.m.- 1:00 pm EDT ... The Ardelyx senior management team will present ... lead compound, tenapanor, which has completed Phase 2b clinical ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... The U.S. Food and Drug Administration is requiring ... on their labels about the risk of a ... systemic fibrosis (NSF), if the drug is administered ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   ...
... (Nasdaq: MSON ), a developer of ... which worldwide is used for acute health conditions, ... distribution agreement with Dismeval, s.l.,  based in Valencia, ... Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone ...
Cached Medicine Technology:FDA: New Warnings Required on Use of Gadolinium-Based Contrast Agents 2Misonix Announces New Distribution Agreement For Spain 2Misonix Announces New Distribution Agreement For Spain 3
(Date:6/30/2015)... ... June 30, 2015 , ... CCAR is pleased to ... Community Centers in Hartford, Willimantic and Bridgeport. This month, staff member Jim Higgins ... Coach Manager. He is excited to take on this role of organizing peer ...
(Date:6/30/2015)... ... June 30, 2015 , ... America’s oldest cancer ... access to cancer prevention, screening and care for the people of Nigeria. Roswell ... that will see Roswell Park faculty providing clinical consultations to assist LCC oncologists, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than just fireworks ... kick off of July as National Hot Dog Month. Americans are expected to eat ... time of the year and enough to stretch from Washington D.C. to Los Angeles ...
(Date:6/30/2015)... ... ... After more than five years of research and development that includes ... specifically formulated for the unique skin of all people of color — is now ... time to help protect the skin of all people of color this July Fourth ...
(Date:6/30/2015)... ... June 30, 2015 , ... LifeAID Beverage Company ... two leading organizations dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, ... is now the official charity of FitAID. I AM ADAPTIVE is a non-profit ...
Breaking Medicine News(10 mins):Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3
... Noted For His Discoveries About Attention And ... April 16 NeuroFocus, the world leader ... the application of brainwave-based measurements for market ... been named a Partner in the company,s ...
... Abbott/Eisai,s Humira Will Earn Decision Resources, Clinical Gold ... to a New Report from Decision ResourcesWALTHAM, Mass., ... world,s leading research and advisory firms for pharmaceutical ... a therapy,s effect on induction of remission as ...
... Next Generation Network magazine has named Zultys as a recipient of the ... , ... Sunnyvale, CA (PRWEB) April 15, 2009 -- Zultys Inc. ... Zultys as a recipient of the First Annual NGN Leadership Award for ...
... 16 WM Healthcare Solutions, Inc. (WMHS), a ... it has purchased substantially all of the assets ... provides pharmaceutical waste management consulting services to the ... and other custom consulting services, in addition to ...
... Workforce Prescriptions ("WRX") announced on Friday the launch of a no-cost online tool developed ... , , Overtime utilization ... Other "Premium Pay" utilization , Excessive ... Process labor waste , Productivity labor waste , ...
... Science adds Sage Intergy EHR as part of its strategy to lead ... 16 Cardiac Science Corporation (Nasdaq: CSCX ), a global ... cardiac stress test , cardiac rehab ... and HIS systems, announced today that it completed certification for its ...
Cached Medicine News:Health News:NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 3Health News:Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine 2Health News:Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine 3Health News:Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine 4Health News:Waste Management Subsidiary Acquires PharmEcology(R) Associates, LLC 2Health News:WRX Launches Hospital Labor Waste Calculator 2Health News:WRX Launches Hospital Labor Waste Calculator 3Health News:Cardiac Science Connects With EMR Partner Sage 2Health News:Cardiac Science Connects With EMR Partner Sage 3Health News:Cardiac Science Connects With EMR Partner Sage 4Health News:Cardiac Science Connects With EMR Partner Sage 5
... If you prefer a standard ... the Volk Iridectomy Lens. Its ... view you're used to but ... Volk's exclusive Double Aspheric design ...
... 2.2 offers extremely high resolution treatment capability ... an exceptionally wide 78° field of view. ... critical evaluation of the optic nerve head ... of the macula and disc. Redesigned to ...
... for focal laser therapy and mid-to-far peripheral ... a realistic contour of the retinal concavity, ... entire posterior pole extending to the equator. ... dynamic movement on the globe, therefore increasing ...
... The Digital 1.0x Imaging Lens is optimized ... reduce glare and reflections during general diagnosis and ... view of the posterior pole and a sharper ... Digital 1.0 X Imaging Lens is also ideal ...
Medicine Products: